Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations

10.1097/JTO.0b013e3181dd1386

Saved in:

Bibliographic Details
Main Authors:	Yeo, W.-L., Lau, M.W., Warner, J.L., Bodio, K., Huberman, M.S., Tenen, D.G., Kobayashi, S., Costa, D.B., Riely, G.J., Kris, M.G., Yeap, B.Y., Pao, W.
Other Authors:	MEDICINE
Format:	Article
Published:	2011
Subjects:	EGFR Epidermal growth factor receptor Erlotinib Exon 19 deletions Gefitinib L858R Lung cancer Mutation Non-small cell lung cancer Tyrosine kinase inhibitors
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/27135
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-27135
record_format	dspace
spelling	sg-nus-scholar.10635-271352024-11-09T11:46:36Z Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations Yeo, W.-L. Lau, M.W. Warner, J.L. Bodio, K. Huberman, M.S. Tenen, D.G. Kobayashi, S. Costa, D.B. Riely, G.J. Kris, M.G. Yeap, B.Y. Pao, W. MEDICINE CANCER SCIENCE INSTITUTE OF SINGAPORE EGFR Epidermal growth factor receptor Erlotinib Exon 19 deletions Gefitinib L858R Lung cancer Mutation Non-small cell lung cancer Tyrosine kinase inhibitors 10.1097/JTO.0b013e3181dd1386 Journal of Thoracic Oncology 5 7 1048-1053 2011-09-27T05:45:08Z 2011-09-27T05:45:08Z 2010 Article Yeo, W.-L., Lau, M.W., Warner, J.L., Bodio, K., Huberman, M.S., Tenen, D.G., Kobayashi, S., Costa, D.B., Riely, G.J., Kris, M.G., Yeap, B.Y., Pao, W. (2010). Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations. Journal of Thoracic Oncology 5 (7) : 1048-1053. ScholarBank@NUS Repository. https://doi.org/10.1097/JTO.0b013e3181dd1386 15560864 15561380 http://scholarbank.nus.edu.sg/handle/10635/27135 000279165200020 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	EGFR Epidermal growth factor receptor Erlotinib Exon 19 deletions Gefitinib L858R Lung cancer Mutation Non-small cell lung cancer Tyrosine kinase inhibitors
spellingShingle	EGFR Epidermal growth factor receptor Erlotinib Exon 19 deletions Gefitinib L858R Lung cancer Mutation Non-small cell lung cancer Tyrosine kinase inhibitors Yeo, W.-L. Lau, M.W. Warner, J.L. Bodio, K. Huberman, M.S. Tenen, D.G. Kobayashi, S. Costa, D.B. Riely, G.J. Kris, M.G. Yeap, B.Y. Pao, W. Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations
description	10.1097/JTO.0b013e3181dd1386
author2	MEDICINE
author_facet	MEDICINE Yeo, W.-L. Lau, M.W. Warner, J.L. Bodio, K. Huberman, M.S. Tenen, D.G. Kobayashi, S. Costa, D.B. Riely, G.J. Kris, M.G. Yeap, B.Y. Pao, W.
format	Article
author	Yeo, W.-L. Lau, M.W. Warner, J.L. Bodio, K. Huberman, M.S. Tenen, D.G. Kobayashi, S. Costa, D.B. Riely, G.J. Kris, M.G. Yeap, B.Y. Pao, W.
author_sort	Yeo, W.-L.
title	Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations
title_short	Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations
title_full	Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations
title_fullStr	Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations
title_full_unstemmed	Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations
title_sort	erlotinib at a dose of 25 mg daily for non-small cell lung cancers with egfr mutations
publishDate	2011
url	http://scholarbank.nus.edu.sg/handle/10635/27135
_version_	1821197595363508224

Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations

Similar Items